A Commons health committee report finds only about 6% of eligible patients will get Mounjaro on the NHS in three years, while most UK GLP-1 packs are bought privately.
Recap by typeshit. Full story at The Independent.
General exercise advice aimed at GLP-1 users, shared on Facebook with no study or expert named in the material available.
Gilead takes global rights to the Shanghai biotech's program, led by HCXT-2001, an oral peptide that could compete with injected IBD drugs.
A Facebook promo for a podcast episode on the ripple effects of GLP-1 consumers across businesses. Few details beyond the pitch.
10:49
xitsnemox posts a short check-in from week 14 on oral Wegovy, two weeks after stepping up to the 25mg tablet. A personal account, not medical advice.
Reuters reports the Hyderabad drugmaker expanded its generic semaglutide lineup to cover a supply-chain problem with its original Obeda brand.
In a USA Today op-ed, she cites her small 25-person vegan diet study where HbA1c fell from 7.6% to 6.6%, and calls on Medicare to pay for nutrition programs.
Loading…